NCT02444767View on ClinicalTrials.gov

Bimatoprost Ocular Insert Pharmacokinetic Study

PHASE1CompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

March 31, 2015

Primary Completion Date

April 30, 2015

Study Completion Date

April 30, 2015

Conditions
Healthy Volunteers
Interventions
DRUG

13mg Bimatoprost Ocular Insert

13mg Bimatoprost Ocular Insert in each eye.

Trial Locations (1)

90701

Sall Medical Research Center, Artesia

All Listed Sponsors
lead

ForSight Vision5, Inc.

INDUSTRY

NCT02444767 - Bimatoprost Ocular Insert Pharmacokinetic Study | Biotech Hunter | Biotech Hunter